Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Cinnaferon vs Betaferon in Relapsing-Remitting Multiple Sclerosis
IRCT201205221859N4Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Jun 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by CinnaGen. Started Jun 2012; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT201205221859N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205221859N4.